603392.SH
万泰生物
SSE · Healthcare · Biotechnology · CN
CNY 28.09
−8.17%Margins
Gross margin
51.3%
EBITDA margin
-6.8%
EBIT margin
-24.3%
Net margin
-20.0%
FCF margin
-41.5%
-3.3%
Return on equity
-2.8%
Return on assets
-3.9%
Return on invested capital
0.14x
Asset turnover
-CNY 56.3M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026